Skip to main content
In stock | Cellular Therapy

Sipuleucel-T

Oncology Type Solid Tumour (Prostate)
Drug Class / Mechanism Autologous Cellular Immunotherapy
No Image
Description

Sipuleucel-T is classified as an Autologous Cellular Immunotherapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cellular Therapy
Oncology Type Solid Tumour (Prostate)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3